Clinical Trial Update: A Multi-centre Open Study to Assess the Safety and Efficacy of Subgam® [Phase 3]

View source ↗

Summary

Phase 3 open-label trial assessing safety and efficacy of Subgam for primary antibody deficiency completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antibody Deficiency

Drugs mentioned

• Subgam

Snippet

Sponsor: Bio Products Laboratory | Conditions: Primary Antibody Deficiency | Phase 3 | Status: COMPLETED